Share

October 2017; 7 (5) Case

Nivolumab-induced posterior reversible encephalopathy syndrome

Haitham M. Hussein, Bradleigh Dornfeld, Daniel J. Schneider
First published April 28, 2017, DOI: https://doi.org/10.1212/CPJ.0000000000000362
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
116

Share

Article Information

vol. 7 no. 5 455-456
DOI: 
https://doi.org/10.1212/CPJ.0000000000000362
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received December 17, 2016
  • Accepted March 22, 2017
  • First Published April 28, 2017.

Article Versions

Copyright & Usage: 
© 2017 American Academy of Neurology

Author Disclosures

    1. Haitham M. Hussein, MD, MSc,
    2. Bradleigh Dornfeld, MD and
    3. Daniel J. Schneider, MD
  1. Haitham M. Hussein, MD, MSc,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editor, Residents and Fellows Section, Journal of Neuroimaging. Editorial board member, Neurology Clinical Practice.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Bradleigh Dornfeld, MD and
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Daniel J. Schneider, MD
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Regions Hospital Comprehensive Stroke Center (HMH), St Paul; Hennepin County Medical Center (BD), Minneapolis; and HealthPartners Clinics and Services (DJS), St Paul, MN.
  1. Correspondence to:
    Haitham.M.Hussein{at}healthpartners.com
View Full Text

Article usage

Article usage: April 2017 to April 2022

AbstractFullPdfSource
Apr 20172601Highwire
May 201716104Highwire
Jun 20176602Highwire
Jul 20177904Highwire
Aug 20178002Highwire
Sep 20172904Highwire
Oct 2017350918Highwire
Nov 2017496211Highwire
Dec 2017148410Highwire
Jan 20187112Highwire
Feb 20186610Highwire
Mar 20185637Highwire
Apr 201874615Highwire
May 20185012Highwire
Jun 20184414Highwire
Jul 20182602Highwire
Aug 20183902Highwire
Sep 20183412Highwire
Oct 20185803Highwire
Nov 20184800Highwire
Dec 20184403Highwire
Jan 20192901Highwire
Feb 20195411Highwire
Mar 20197136Highwire
Apr 20192000Highwire
May 20192500Highwire
Jun 20192242Highwire
Jul 20193520Highwire
Aug 20192510Highwire
Sep 20192520Highwire
Oct 20191812Highwire
Nov 20194510Highwire
Dec 20194210Highwire
Jan 20202201Highwire
Feb 20204200Highwire
Mar 20202000Highwire
Apr 20202500Highwire
May 20203200Highwire
Jun 20201500Highwire
Jul 20201300Highwire
Aug 20201610Highwire
Sep 20201210Highwire
Oct 20202800Highwire
Nov 20201600Highwire
Dec 20201701Highwire
Jan 20211600Highwire
Feb 20211511Highwire
Mar 20212020Highwire
Apr 20211100Highwire
May 20212521Highwire
Jun 20212122Highwire
Jul 20212310Highwire
Aug 20213000Highwire
Sep 20212410Highwire
Oct 20213600Highwire
Nov 20211400Highwire
Dec 20211400Highwire
Jan 20223400Highwire
Feb 20221510Highwire
Mar 20222000Highwire
Apr 20221700Highwire

Cited By...

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me